RAYMOND JAMES & ASSOCIATES - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 25 filers reported holding ACER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$37,000
-9.8%
16,2000.0%0.00%
Q3 2021$41,000
-10.9%
16,2000.0%0.00%
Q2 2021$46,000
-8.0%
16,2000.0%0.00%
Q1 2021$50,000
+19.0%
16,2000.0%0.00%
Q4 2020$42,000
-10.6%
16,2000.0%0.00%
Q3 2020$47,000
-16.1%
16,2000.0%0.00%
Q2 2020$56,000
+75.0%
16,2000.0%0.00%
Q1 2020$32,000
-52.2%
16,200
-3.0%
0.00%
Q4 2019$67,000
+26.4%
16,7000.0%0.00%
Q3 2019$53,000
-91.7%
16,700
-89.8%
0.00%
-100.0%
Q2 2019$637,000
-49.5%
163,332
+214.6%
0.00%
-50.0%
Q1 2019$1,262,00051,9220.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,226,191$3,077,7390.20%
Knott David M Jr 140,000$3510.13%
Anson Funds Management LP 129,795$325,7850.05%
Meridian Wealth Management, LLC 71,750$180,0930.02%
Anson Funds Management LP 38,100$95,6310.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 19,000$480.01%
Virtu Financial LLC 10,557$260.00%
TWO SIGMA SECURITIES, LLC 19,747$49,5650.00%
UBS Group AG 1,393$3,4970.00%
SVB WEALTH LLC 11,500$28,8650.00%
View complete list of ACER THERAPEUTICS INC shareholders